Drug application
CYSTEINE HYDROCHLORIDE (CYSTEINE HYDROCHLORIDE)
Drugs@FDA NDA 019523 · HOSPIRA
Key facts
| Drug name | CYSTEINE HYDROCHLORIDE |
|---|---|
| Active ingredients | CYSTEINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 019523 |
| Company | HOSPIRA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 7.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Oct 22, 1986 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.